Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Heart and Lung Transplantation"
DOI: 10.1016/j.healun.2021.01.1766
Abstract: Purpose Inhaled pulmonary vasodilators (iPVD) are commonly used to lower PVR to modify the risk of acute RV failure in durable LVAD implantation or orthotopic heart transplantation (OHT). While inhaled nitric oxide (iNO) is the…
read more here.
Keywords:
advanced heart;
heart;
treatment;
failure ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Heart and Lung Transplantation"
DOI: 10.1016/j.healun.2021.01.1925
Abstract: Purpose Inhaled pulmonary vasodilators (iPVD) are commonly used in lung transplant recipients to mitigate the risk of primary graft dysfunction (PGD). While inhaled nitric oxide (iNO) is the gold standard for iPVD therapy, inhaled epoprostenol…
read more here.
Keywords:
treatment;
transplantation;
ino;
pulmonary vasodilators ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Interventional Cardiology"
DOI: 10.1155/2022/7602793
Abstract: Background Fontan-associated liver disease is a well-known sequela following the Fontan procedure for patients living with single-ventricle heart disease. Pulmonary vasodilators, such as phosphodiesterase type 5 inhibitors, have emerged as a potential therapeutic option for…
read more here.
Keywords:
patients fontan;
pulmonary vasodilators;
selective use;
physiology ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Pulmonary Circulation"
DOI: 10.1177/20458940211015823
Abstract: Few meta-analyses evaluated the efficacy and safety of pulmonary vasodilators in patients with Eisenmenger syndrome. Recently, some studies have reported conflicting results regarding improvements in exercise capacity. This study evaluated the efficacy and safety of…
read more here.
Keywords:
patients eisenmenger;
eisenmenger syndrome;
efficacy safety;
safety pulmonary ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Pulmonary Circulation"
DOI: 10.1177/2045894021991446
Abstract: Development of pulmonary hypertension (PH) in patients with left side heart disease (LHD) is a predictor of poor prognosis. The use of pulmonary vasodilators in PH associated with LHD (PH-LHD) is controversial. In this study,…
read more here.
Keywords:
heart;
pulmonary hypertension;
pulmonary vasodilators;
use pulmonary ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Life"
DOI: 10.3390/life12060780
Abstract: Background: In patients with chronic kidney disease (CKD) on hemodialysis, comorbid pulmonary hypertension (PH) aggravates exercise tolerance and eventually worsens the prognosis. The treatment strategy for pre-capillary PH, including combined pre- and post-capillary PH (Cpc-PH),…
read more here.
Keywords:
pulmonary vasodilators;
patients chronic;
chronic kidney;
hemodialysis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Respiratory Care"
DOI: 10.4187/respcare.05360
Abstract: Inhaled nitric oxide (INO) is only FDA-cleared for neonates (> 34 weeks gestation) with hypoxic respiratory failure-associated pulmonary hypertension. Off-label use of INO is common in the pediatric population despite a lack of evidence regarding…
read more here.
Keywords:
vasodilators indications;
indications within;
inhaled pulmonary;
pediatric icu ... See more keywords